Awards & Advancement

Premier Research Groups names VP of human resources

Monday, August 1, 2011 12:44 PM

Premier Research Group has named Mark P. Sneff vice president, human resources. In this role, Sneff will be responsible for the global human resources function and staff in support of Premier Research’s strategic goals.

More... »

Omthera names Lloyd VP regulatory affairs

Monday, August 1, 2011 12:32 PM

Omthera Pharmaceuticals reports that Ramona M. Lloyd has joined the company as vice president regulatory affairs, effective immediately.  In this newly created position, Dr. Lloyd will be responsible for the management of all regulatory activities, including regulatory strategy and interactions with the FDA.

More... »

RecipharmCobra Biologics names commercial director

Monday, August 1, 2011 12:29 PM

RecipharmCobra Biologics, the international manufacturer of biopharmaceuticals, has named Julian Hanak its commercial director. Julian will join the RecipharmCobra management team to build on the company’s growth in provision of manufacturing services for the biotech and biopharmaceutical industry.

More... »

TKL Research names VP of operational excellence

Monday, August 1, 2011 12:27 PM

TKL Research has named Kevin Vernarec, vice president of operational excellence. In this new role, Vernarec will carry the responsibility for ensuring that all clinical research organization (CRO) systems and processes are performed with optimum quality and are executed utilizing appropriately allocated resources.

More... »

Sanofi names senior VP of global services

Monday, August 1, 2011 12:22 PM

Sanofi has named Greg Irace, currently president and CEO of Sanofi's US operations, its senior vice president, global services, a newly created role. He will lead the global information systems function, be responsible for shared support functions across all Sanofi businesses in North America and play a key role in the development of a global strategy for shared services. Irace will continue to be a member of the Global Management Committee. He will be based in Bridgewater, New Jersey.

More... »

gIcare receives $7M series A financing

Monday, August 1, 2011 12:19 PM

gIcare Pharma has closed a $7 million Series A financing round to develop a novel alternative to perform safe, painless colonoscopies without sedation. In addition to offering clinical benefits during the procedure, GIC-1001's use does not require a recovery room or particular medical assistance post-colonoscopy. This colonic analgesic approach aligns well with the current global strategy to reduce healthcare costs.

More... »

Roche names president of Ventana Medical Systems

Monday, August 1, 2011 12:09 PM

Ventana Medical Systems, a member of the Roche Group, has named Mara Aspinall president. Aspinall will begin her new role at Ventana in September 2011.

More... »

EMA recommends INCIVO for hepatitis C virus

Friday, July 29, 2011 10:25 AM

Tibotec Virco-Virology BVBA, part of Janssen Pharmaceutical, reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the approval of INCIVO (telaprevir), a direct acting antiviral (DAA) for the treatment of chronic genotype-1 hepatitis C virus (HCV), in combination with pegylated-interferon and ribavirin, the previously accepted standard of care.

More... »

Paragon names VP of pre-clinical services and process development

Friday, July 22, 2011 10:24 AM

Paragon Bioservices has named Vadim Klyushnichenko, Ph.D., vice president, pre-clinical services and process development.  He will report to Paragon's president and CEO Marco Chacon, Ph.D.

More... »

Nevro completes $58 million financing round

Friday, July 22, 2011 10:22 AM

Nevro, a neuromodulation company focused on relief of chronic pain, has completed a $58 million financing round led by new investor Johnson & Johnson Development (JJDC). Existing investors Aberdare Ventures, Accuitive Medical Ventures, Bay City Capital, Mayo Clinic, MPM Capital and Three Arch Partners also participated.

More... »